JPRN-UMIN000000549
Completed
Phase 2
A phase II study to evaluate the effect of adjuvant chemotherapy using hepatic arterial infusion chemotherapy of 5-fluorouracil plus systemic chemotherapy of gemcitabine after resection of pancreatic cancer - A phase II study to evaluate the effect of adjuvant chemotherapy using hepatic arterial 5FU plus systemic gemcitabine after resection of pancreatic cancer
ara Medical University0 sites25 target enrollmentDecember 15, 2006
Conditionsresectable pancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- resectable pancreatic cancer
- Sponsor
- ara Medical University
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) interstitial pneumonia, pulmonary fibrosis 2\) intractable pleural effusion 3\) intractable diabetes mellitus or liver dysfunction 4\) distant metastasis 5\) other active cancers 6\) apparent infection 7\) sever postoperative complications 8\) active peptic ulcer 9\) episode of myocardial infarction within three months 10\) mental disorders 11\) pregnacy or patient's hope to be pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Study on the clinical efficacy of adjuvant BGP-15 treatment additional to beta-blocker bisoprolol in patients with inappropriate sinus tachycardiaInappropriate sinus tachycardiaMedDRA version: 20.0Level: LLTClassification code 10043083Term: Tachycardia sinusSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-003005-61-HUSinusventure LLC.20
Not yet recruiting
Not Applicable
A study to assess effectiveness of hydrogel and honey in treatment of diabetic foot ulcer among diabetic patients residing in rural areas of nelloreCTRI/2020/12/030103arayana College Of Nursing
Recruiting
Phase 2
Study with apalutamide in patients with prostate cancer in whom the prostate has been removed who are at high risk of disease recurrence2024-511832-29-00Universitaet Muenster190
Active, not recruiting
Phase 1
Clinical trial for the evaluation of a new drug (cabozantinib) treatment given before having kidney surgery in patients with kidney cancer that is advanced or has spreadocally Advanced or Metastatic Renal Cell CarcinomaMedDRA version: 20.0Level: PTClassification code 10050513Term: Metastatic renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-001201-93-ESFundación ONCOSUR50
Recruiting
Phase 2
eoadjuvant DOS treatment for advanced esophageal cancerJPRN-jRCTs041210023Kodera Yasuhiro45